126 related articles for article (PubMed ID: 327096)
1. Commentary on the immunobiology of bladder cancer.
Catalona WJ
J Urol; 1977 Jul; 118(1 Pt 1):2-6. PubMed ID: 327096
[TBL] [Abstract][Full Text] [Related]
2. Immunobiology of human bladder cancer.
Herr HW
J Urol; 1976 Feb; 115(2):147-9. PubMed ID: 765496
[TBL] [Abstract][Full Text] [Related]
3. Some immunological considerations relevant to the study of human bladder cancer.
Bean MA
Cancer Res; 1977 Aug; 37(8 Pt 2):2879-84. PubMed ID: 326394
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immune reactions to human tumors.
Perlmann P; Troye M; Pape GR
Cancer; 1977 Jul; 40(1 Suppl):448-57. PubMed ID: 69485
[No Abstract] [Full Text] [Related]
5. Lymphocyte mediated cytotoxicity to tumor antigens.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
[No Abstract] [Full Text] [Related]
6. Cell-mediated immune mechanisms of tumor cell destruction.
Perlmann P; O'Toole C; Unsgaard B
Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
[No Abstract] [Full Text] [Related]
7. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
Perlmann P; O'Toole C; Unsgaard B
Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
[No Abstract] [Full Text] [Related]
8. The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer.
Vilien M; Wolf H
J Urol; 1978 Mar; 119(3):338-42. PubMed ID: 273706
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytic reaction associated with bladder cancer. Effect of chronic immunosuppression.
Soloway MS; Myers GH; Krueger G
Urology; 1974 Apr; 3(4):437-43. PubMed ID: 4822692
[No Abstract] [Full Text] [Related]
10. Immune response in bladder cancer patients.
Brosman S; Elhilali M; Vescera C; Fahey J
J Urol; 1979 Feb; 121(2):162-9. PubMed ID: 423328
[No Abstract] [Full Text] [Related]
11. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.
Bubeník J; Baresová M; Viklický V; Jakoubková J; Sainerová H; Donner J
Int J Cancer; 1973 May; 11(3):765-73. PubMed ID: 4133950
[No Abstract] [Full Text] [Related]
12. Classification of the bladder cancer patient based on in vitro measurements of the immune response.
Lange PH; Hakala TR; Fraley EE
Cancer Res; 1977 Aug; 37(8 Pt 2):2885-90. PubMed ID: 326395
[TBL] [Abstract][Full Text] [Related]
13. The cellular immune response to carcinoma of the urinary bladder: correlation to clinical stage and treatment.
O'Toole C; Unsgaard B; Almgård LE; Johansson B
Br J Cancer Suppl; 1973 Aug; 1():266-75. PubMed ID: 4804285
[TBL] [Abstract][Full Text] [Related]
14. Murine bladder tumors as models for human tumor immunity.
Hellström I; Hellström KE
Natl Cancer Inst Monogr; 1972 Dec; 35():125-7. PubMed ID: 4659043
[No Abstract] [Full Text] [Related]
15. Immunological studies on urinary bladder tumors of rats and mice.
Taranger LA; Chapman WH; Hellström I; Hellström KE
Science; 1972 Jun; 176(4041):1337-40. PubMed ID: 5034547
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of immunological reactivity in bladder cancer.
O'Boyle PJ; Cooper EH; Williams RE
Br J Urol; 1974 Jun; 46(3):303-8. PubMed ID: 4843725
[No Abstract] [Full Text] [Related]
17. [The lymphocyte cytotoxicity test in tumor immunology (author's transl)].
Pees HW
Klin Wochenschr; 1975 Jan; 53(1):1-6. PubMed ID: 47411
[TBL] [Abstract][Full Text] [Related]
18. In vitro-demonstration of cellular hypersensitivity to tumour antigens in man.
Andersen V; Kjaer M; Bendixen G
Ser Haematol; 1972; 5(5):3-21. PubMed ID: 4598039
[No Abstract] [Full Text] [Related]
19. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
Haba S; Kitagawa M
Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
[No Abstract] [Full Text] [Related]
20. Immunologic evaluation of human bladder cancer: in vitro studies.
Elhilali MM; Nayak SK
Cancer; 1975 Feb; 35(2):419-31. PubMed ID: 1111918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
